AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H1708-H1716, 2005. First published December 9, 2004; doi:10.1152/ajpheart.00911.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/H1708    most recent
00911.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.

Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution

Pedro Cabrales, Amy G. Tsai, and Marcos Intaglietta

Department of Bioengineering, University of California-San Diego, and La Jolla Bioengineering Institute, La Jolla, California

Submitted 2 September 2004 ; accepted in final form 2 December 2004

Extreme hemodilution was performed in the hamster chamber window model using 6% Dextran 70, lowering systemic hematocrit by 60%. Animals were subsequently divided into three groups and hemodiluted to a hematocrit of 11% using 6% Dextran 70, 6% Dextran 500, and a 4% Dextran 70 + 0.7% alginate solution (n = 6 each group). Final plasma viscosities were 1.4 ± 0.2, 2.2 ± 0.1, and 2.7 ± 0.2 cp, respectively, (P < 0.05, high viscosity vs. low viscosity). Blood viscosities were 2.1 ± 0.2, 2.9 ± 0.4, and 3.9 ± 0.3 cp, respectively. The lowest blood and plasma viscosity group had a significantly lower functional capillary density, 37 ± 16%, whereas the two high-viscosity solutions were 71 ± 15% and 76 ± 12% (P < 0.05, high viscosity vs. low viscosity), respectively. Arteriolar and venular flow in the Dextran 500 and alginate groups was higher than baseline (i.e., normal nontreated animals), whereas the low-viscosity group showed a reduction in flow. These microvascular changes were paralleled by changes in base excess, which was negative for the Dextran 70 group and positive for the other groups. However, tissue PO2 was uniformly low for all groups (average of 1.4 mmHg). Calculation of tissue oxygen consumption in the window chamber based on the microvascular data, flow, and intravascular PO2 showed that only the alginate + Dextran 70 solution-exchanged animals returned to baseline oxygen consumption, whereas the other groups were lower than baseline (P < 0.05). These results show that hemodilution performed with high-viscosity plasma expanders yields systemic arterial pressures and functional capillary densities that are significantly higher (P < 0.05) than those obtained with 6% Dextran 70, a fluid whose viscosity is similar to that of plasma. A condition for obtaining these results is that the oncotic pressure of the plasma expander be titrated to near normal, so that autotransfusion of fluid from the tissue into the vascular compartment does not reduce the effects of increasing plasma viscosity and increased shear stress on the microvascular wall.

shear stress; blood pressure; functional capillary density



Address for reprint requests and other correspondence: P. Cabrales, Univ. of California-San Diego, Dept. of Bioengineering, 0412, 9500 Gilman Dr., La Jolla, CA 92093-0412 (E-mail: pcabrales{at}ucsd.edu)




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Leor, S. Tuvia, V. Guetta, F. Manczur, D. Castel, U. Willenz, O. Petnehazy, N. Landa, M. S. Feinberg, E. Konen, et al.
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
J. Am. Coll. Cardiol., September 8, 2009; 54(11): 1014 - 1023.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Cabrales, A. G. Tsai, P. C. Johnson, and M. Intaglietta
Oxygen release from arterioles with normal flow and no-flow conditions
J Appl Physiol, May 1, 2006; 100(5): 1569 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, A. G. Tsai, R. M. Winslow, and M. Intaglietta
Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2392 - H2400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. G. Tsai, P. Cabrales, P. C. Johnson, M. Intaglietta, A. S. Golub, and R. N. Pittman
Effect of oxygen consumption by measuring method on PO2 transients associated with the passage of erythrocytes in capillaries of rat mesentery
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1777 - H1779.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.